Breast Cancer Prevention Drug Linked to Bone Loss

Exemestane increases bone loss despite calcium and vitamin D supplementation

TUESDAY, Feb. 7 (HealthDay News) -- Postmenopausal women receiving the aromatase inhibitor exemestane to prevent breast cancer are more likely to have bone loss, according to a study published online Feb. 7 in The Lancet Oncology.

Angela M. Cheung, M.D., from the University Health Network in Toronto, and colleagues analyzed bone mineral density (BMD) data from 351 postmenopausal women (median age, 61.3 years) who had been randomized to receive placebo or exemestane as part of a breast cancer prevention clinical trial.

After two years, the researchers found that, at the distal radius, total volumetric BMD and cortical thickness fell significantly more in women receiving exemestane compared with placebo (mean loss, 6.1 versus 1.8 percent and 7.9 versus 1.1 percent, respectively). Similar results were observed at the distal tibia (mean loss, 5.0 versus 1.3 percent and 7.6 versus 0.7 percent, respectively). Areal BMD also fell significantly more in the exemestane group at the lumbar spine, total hip, and femoral neck.

"Two years of treatment with exemestane worsens age-related bone loss in postmenopausal women despite calcium and vitamin D supplementation," Cheung and colleagues conclude. "To assess the effect of our findings on fracture risk, long-term follow-up is needed."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95

The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95

Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.

Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.

Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.

More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events